News

State legislators are moving to advance US Health and Human Services Secretary Robert F. Kennedy Jr.’s push for greater ...
University of Delaware's Mona Batish is a molecular biologist. She studies circular RNAs formed as a result of so-called ...
GSK's (GSK) stock rises as the company's Arexvy shot could see expanded CDC recommendations for RSV protection in at-risk ...
After Dr. Anthony Fauci spoke at the Van Wezel in Sarasota, a group of people gathered downtown to offer a counterpoint.
Researchers from Agency for Science, Technology and Research in Singapore recently published a review article exploring how ...
The investigational mRNA-1010 influenza vaccine has undergone extensive clinical evaluation in a series of trials involving ...
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicine company ...
Home > Pressemitteilung: New solutions for the RNA medicine of ... At the RNApp graduate school, young researchers are working to make RNA-based drugs safer and more effective.
Arcturus Therapeutics Holdings has won U.S. Food and Drug Administration fast-track designation for its ARCT-2304 pandemic flu vaccine candidate.
COVID-19 vaccination during pregnancy was not associated with major structural birth defects, according to a study published ...
CDMO, AGC Biologics, announced a strategic decision about the large-scale single-use technology it will use at its new ...